Favorable long-term outcome after liver-kidney transplant for recurrent hemolytic uremic syndrome associated with a factor H mutation.
about
Atypical hemolytic uremic syndromeRecurrent atypical hemolytic uremic syndrome associated with factor I mutation in a living related renal transplant recipientRelative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotypePre-emptive eculizumab and plasmapheresis for renal transplant in atypical hemolytic uremic syndromePathogenesis of thrombotic microangiopathiesSpontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains.Complement in glomerular injury.Successful liver-kidney transplantation in two children with aHUS caused by a mutation in complement factor H.Translational mini-review series on complement factor H: therapies of renal diseases associated with complement factor H abnormalities: atypical haemolytic uraemic syndrome and membranoproliferative glomerulonephritis.Plasma therapy in atypical haemolytic uremic syndrome: lessons from a family with a factor H mutation.Successful split liver-kidney transplant for factor H associated hemolytic uremic syndrome.A large family with a gain-of-function mutation of complement C3 predisposing to atypical hemolytic uremic syndrome, microhematuria, hypertension and chronic renal failure.Eculizumab induces long-term remission in recurrent post-transplant HUS associated with C3 gene mutation.Complement activation during liver transplantation-special emphasis on patients with atypical hemolytic uremic syndrome.Changing strategies for organ transplantation in atypical haemolytic uraemic syndrome: a tertiary case series.Novel use of intravenous immunoglobulin G in complement factor H missense mutation: a case report.Complement regulation in renal disease modelsUse of eculizumab and plasma exchange in successful combined liver-kidney transplantation in a case of atypical HUS associated with complement factor H mutation.The importance of genetic mutation screening to determine retransplantation following failed kidney allograft from recurrent atypical haemolytic ureamic syndromeLiver transplantation for aHUS: still needed in the eculizumab era?Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis.Anesthetic management of living donor liver transplantation for complement factor H deficiency hemolytic uremic syndrome: a case report.Atypical hemolytic uremic syndrome and mutation analysis of factor H gene in two Tunisian families.A single center experience of combined liver kidney transplantation.Kidney Transplantation in Patients with Atypical Hemolytic Uremic Syndrome due to Complement Factor H Deficiency: Impact of Liver Transplantation.Long-term successful liver-kidney transplantation in a child with atypical hemolytic uremic syndrome caused by homozygous factor H deficiency.Actual and future strategies for transplantation in atypical HUS associated with mutations in factor H.Atypical hemolytic uremic syndromeManagement of hemolytic uremic syndrome
P2860
Q21202864-805CC828-9419-4E74-B732-A73624E3A1FEQ24601710-8121DE33-719F-415F-B229-72BD63AE23E6Q24613907-D0CAD05B-93E2-492C-BF3C-99644DF4C6B0Q24622189-172521EA-F7E3-46C0-9AC2-17DAE0D492FDQ24658043-76AA1D83-0D02-4E9C-AA2F-77095DCBA58EQ33375335-DC201F48-D72E-48AC-B761-D64C83B40E03Q33376840-71B2525D-E1C9-4642-B996-4710B0BA2D5DQ33377223-59633D2F-86B4-4A80-AC94-968AE3F4AD72Q33377727-67270FE0-BD66-4264-8F99-12508672CAA6Q33379624-1D92ADF2-DE8E-481B-8974-2405BC3A25B7Q33381980-42848E02-1542-4786-B212-E7EC9403632AQ33385329-C080529E-A41A-4D69-B916-2C1E7A68B1EDQ33393107-E904ED6D-1226-4255-8CAC-0CE94AE7FE7CQ33396528-478A70CE-3110-4905-AD52-A89A2282D0B4Q33406251-4846AFC0-D45D-4277-A41C-6344212B53CDQ33410111-B7F46DA1-62DF-4992-B18B-DA136F91DC5FQ33411137-72C8D0DA-97FE-4F81-9BA2-D3B44285E4C7Q33411421-70812817-E097-4A5E-9DEA-FCFC217EB71BQ33414227-478FF913-BE7D-4602-88FD-AD2CEBB270A6Q33427846-C47ADEAF-1031-4768-99AB-7DE7262A3A72Q34122035-0FC4B4B3-892E-4F9B-A50E-C20C72DEE28CQ34663061-0B08DEE9-F61F-4DE9-BB99-38CC7AFE50E3Q35026701-83227668-DED4-4D98-B4A3-408AF39224BFQ37636489-046EFBA6-8D97-4B77-B7E4-CA69389429A2Q47102552-6FE3FE97-6A98-4C62-8FA9-99F82C91951AQ48299781-30809722-E9B7-485A-9C28-12FCCA01F4BDQ51714954-39B1D45E-1ABA-4CB9-B109-63D3BEC9BD75Q56591965-37284051-77D6-4AC9-A62B-BE2310762AE4Q57161996-9968B433-B664-4C2A-AB1A-FFF1CEDD7B9C
P2860
Favorable long-term outcome after liver-kidney transplant for recurrent hemolytic uremic syndrome associated with a factor H mutation.
description
2006 nî lūn-bûn
@nan
2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Favorable long-term outcome af ...... ated with a factor H mutation.
@ast
Favorable long-term outcome af ...... ated with a factor H mutation.
@en
type
label
Favorable long-term outcome af ...... ated with a factor H mutation.
@ast
Favorable long-term outcome af ...... ated with a factor H mutation.
@en
prefLabel
Favorable long-term outcome af ...... ated with a factor H mutation.
@ast
Favorable long-term outcome af ...... ated with a factor H mutation.
@en
P2093
P2860
P1476
Favorable long-term outcome af ...... ated with a factor H mutation.
@en
P2093
Benchimol C
Bromberg JS
Goodship TH
Shneider BL
P2860
P304
P356
10.1111/J.1600-6143.2006.01375.X
P407
P577
2006-08-01T00:00:00Z